Page 131 - Cardiac Nursing

M
M
Pa
Pa
M
0:4
0:4
0 A
0 A
7-1
7-1
09
09
e 1
g
g
e 1
g
xd
xd
3
3
q
q
q
10.
10.
009
009
1
1
6/2
0/0
3
6/2
0/0
t
ara
t
p
04_
0-c
K34
0-c
ara
ara
K34
07
04_
A
A
p
LWBK340-c04_ p p pp097-110.qxd 30/06/2009 10:40 AM Page 107 Aptara
p
07
CHAP TER 4 / Genetics 107
20. Fruchart, J. C., & Duriez, P. (2002). HDL and triglyceride as therapeu- 49. Day, I. N., Whittall, R. A., O’Dell, S. D., et al. (1997). Spectrum of
tic targets. Current Opinion in Lipidology, 13(6), 605–616. LDL receptor gene mutations in heterozygous familial hypercholes-
21. Goldbourt, U., & Neufeld, H. N. (1986). Genetic aspects of arte- terolemia. Human Mutation, 10(2), 116–127.
6
riosclerosis. Arteriosclerosis, 6(4), 357–377. 50. Hobbs, H. H., Brown, M. S., & Goldstein, J. L. (1992). Molecular ge-
6
22. Shepard, D. R., Jneid, H., & Thacker, H. L. (2003). Gender, hyperlipi- netics of the LDL receptor gene in familial hypercholesterolemia. Hu-
demia, and coronary artery disease. Comprehensive Therapy, 29(1), 7–17. man Mutation, 1(6), 445–466.
23. Kugiyama, K., Ota, Y., Takazoe, K., et al. Circulating levels of secretory 51. Tybjaerg-Hansen, A., Steffensen, R., Meinertz, H., et al. (1998). Associ-
type II phospholipase A(2) predict coronary events in patients with coro- ation of mutations in the apolipoprotein B gene with hypercholes-
nary artery disease. Circulation, 100(12), 1280–1284. terolemia and the risk of ischemic heart disease. New England Journal of
24. Lusis, A. J., Weinreb, A., & Drake, T. (1998). Textbook of cardiovascular Medicine, 338(22), 1577–1584.
medicine. Philadelphia: Lippincott-Raven. 52. Haines, J., & Pericak-Vance, M. (2006). Genetic analysis of complex dis-
25. Steinberg, D., & Witztum, J. (1999). Molecular basis of cardiovascular eases. Hoboken, NJ: Wiley-Liss.
disease. Philadelphia: Saunders. 53. Allen, G., Harvald, B., & Shields, J. (1967). Measures of twin concor-
7
26. Hu, H., Pierce, G. N., & Zhong, G. (1993). The atherogenic effects of dance. Acta Genetica et Statistica Medica, 17(6), 475–481.
7
chlamydia are dependent on serum cholesterol and specific to Chlamy- 54. Berg, K. (1984). Twin studies of coronary heart disease and its risk fac-
dia pneumoniae. Journal of Clinical Investigations, 103(5), 747–753. tors. Acta Geneticae Medicae et Gemellologiae (Roma), 33(3), 349–361.
7
27. Lusis, A. J. (2000). Atherosclerosis. Nature, 407(6801), 233–241. 55. Cederlof, R., Friberg, L., & Jonsson, E. (1967). Hereditary factors and
7
28. Lefkowitz, R. J., & Willerson, J. T. (2001). Prospects for cardiovascular “angina pectoris.” A study on 5,877 twin-pairs with the aid of mailed
research. JAMA, 285(5), 581–587. questionnaires. Archives of Environmental Health, 14(3), 397–400.
29. Rauch, U., Osende, J. I., Fuster, V., et al. (2001). Thrombus formation 56. de Faire, U., Friberg, L., & Lundman, T. (1975). Concordance for mor-
on atherosclerotic plaques: Pathogenesis and clinical consequences. tality with special reference to ischaemic heart disease and cerebrovascu-
Annals of Internal Medicine, 134(3), 224–238. lar disease. A study on the Swedish Twin Registry. Preventive Medicine,
30. Weissberg, P. L. (2000). Atherogenesis: Current understanding of the 4(4), 509–517.
causes of atheroma. Heart, 83(2), 247–252. 57. Marenberg, M. E., Risch, N., Berkman, L. F., et al. (1994). Genetic sus-
31. Scheuner, M. T. (2001). Genetic predisposition to coronary artery dis- ceptibility to death from coronary heart disease in a study of twins. New
6
6
ease. Current Opinion in Cardiology, 16(4), 251–260. England Journal of Medicine, 330(15), 1041–1046.
32. Orso, E., Broccardo, C., Kaminski, W. E., et al. (2000). Transport of 58. Mosteller, M. (1993). A genetic analysis of cardiovascular disease risk
lipids from golgi to plasma membrane is defective in tangier disease pa- factor clustering in adult female twins. Genetics and Epidemiology, 10(6),
tients and Abc1-deficient mice. Natural Genetics, 24(2), 192–196. 569–574.
33. Young, S. G., & Fielding, C. J. (1999). The ABCs of cholesterol efflux. 59. Reed, T., Quiroga, J., Selby, J. V., et al. (1991). Concordance of ischemic
Natural Genetics, 22(4), 316–318. heart disease in the NHLBI twin study after 14–18 years of follow-up.
34. Luft, F. C. (1998). Molecular genetics of human hypertension. Journal Journal of Clinical Epidemiology, 44(8), 797–805.
6
of Hypertension, 16(12, Pt. 2), 1871–1878. 60. Nora, J. J., Lortscher, R. H., Spangler, R. D., et al. (1980). Genetic–
6
35. Geller, D. S., Farhi, A., Pinkerton, N., et al. (2000). Activating miner- epidemiologic study of early-onset ischemic heart disease. Circulation,
alocorticoid receptor mutation in hypertension exacerbated by preg- 61(3), 503–508.
nancy. Science, 289(5476), 119–123. 61. Rissanen, A. M. (1979). Familial occurrence of coronary heart disease:
36. Cohen, J. C., Wang, Z., Grundy, S. M., et al. (1994). Variation at the Effect of age at diagnosis. American Journal of Cardiology, 44(1), 60–66.
hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of 62. Rose, G. (1964). Familial patterns in ischaemic heart disease. British
genetically determined variation in plasma HDL cholesterol levels. Journal of Preventive and Social Medicine, 18, 75–80.
Journal of Clinical Investigations, 94(6), 2377–2384. 63. Slack, J., & Evans, K. A. (1966). The increased risk of death from is-
37. Wittrup, H. H., Tybjaerg-Hansen, A., & Nordestgaard, B. G. (1999). chaemic heart disease in first degree relatives of 121 men and 96 women
Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of with ischaemic heart disease. Journal of Medical Genetics, 3(4), 239–257.
ischemic heart disease. A meta-analysis. Circulation, 99(22), 2901–2907. 64. Thomas, C. B., & Cohen, B. H. (1955). The familial occurrence of hy-
38. Samani, N. J., Thompson, J. R., O’Toole, L., et al. (1996). A meta-analysis pertension and coronary artery disease, with observations concerning
of the association of the deletion allele of the angiotensin-converting enzyme obesity and diabetes. Annals of Internal Medicine, 42(1), 90–127.
gene with myocardial infarction. Circulation, 94(4), 708–712. 65. Barrett-Connor, E., & Khaw, K. (1984). Family history of heart attack
4
4
39. Hegele, R. A. (1999). Paraoxonase genes and disease. Annals of Medicine, as an independent predictor of death due to cardiovascular disease.
31(3), 217–224. Circulation, 69(6), 1065–1069.
40. Shih, P. T., Brennan, M. L., Vora, D. K., et al. (1999). Blocking very late 66. Colditz, G. A., Rimm, E. B., Giovannucci, E., et al. (1991). A prospec-
antigen-4 integrin decreases leukocyte entry and fatty streak formation tive study of parental history of myocardial infarction and coronary ar-
7
in mice fed an atherogenic diet. Circulation Research, 84(3), 345–351. tery disease in men. American Journal of Cardiology, 67(11), 933–938.
7
41. Tuomainen, T. P., Kontula, K., Nyyssonen, K., et al. Increased risk of 67. Colditz, G. A., Stampfer, M. J., Willett, W. C., et al. (1986). A prospec-
acute myocardial infarction in carriers of the hemochromatosis gene tive study of parental history of myocardial infarction and coronary heart
Cys282Tyr mutation: A prospective cohort study in men in eastern Fin- disease in women. American Journal of Epidemiology, 123(1), 48–58.
land. Circulation, 100(12), 1274–1279. 68. Hopkins, P. N., Williams, R. R., Kuida, H., et al. (1988). Family history
42. Hingorani, A. D., Liang, C. F., Fatibene, J., et al. (1999). A common as an independent risk factor for incident coronary artery disease in a
S
S
variant of the endothelial nitric oxide synthase (Glu298SAsp) is a ma- high-risk cohort in Utah. American Journal of Cardiology, 62(10, Pt. 1),
jor risk factor for coronary artery disease in the UK. Circulation, 703–707.
100(14), 1515–1520. 69. Phillips, A. N., Shaper, A. G., Pocock, S. J., et al. (1988). Parental death
43. Franco, R. F., Pazin-Filho, A., Tavella, M. H., et al. (2000). Factor XIII from heart disease and the risk of heart attack. European Heart Journal,
val34leu and the risk of myocardial infarction. Haematologica, 85(1), 67–71. 9(3), 243–251.
44. Lloyd-Jones, D. M., Larson, M. G., Beiser, A., et al. (1999). Lifetime 70. Schildkraut, J. M., Myers, R. H., Cupples, L. A., et al. (1989). Coronary
risk of developing coronary heart disease. Lancet, 353(9147), 89–92. risk associated with age and sex of parental heart disease in the Framing-
45. Cargill, M., Altshuler, D., Ireland, J., et al. (1999). Characterization of ham Study. American Journal of Cardiology, 64(10), 555–559.
single-nucleotide polymorphisms in coding regions of human genes. 71. Sholtz, R. I., Rosenman, R. H., & Brand, R. J. (1975). The relationship
Natural Genetics, 22(3), 231–238. of reported parental history to the incidence of coronary heart disease in
46. Krushkal, J., Xiong, M., Ferrell, R., et al. (1998). Linkage and associa- the Western Collaborative Group Study. American Journal of Epidemiol-
tion of adrenergic and dopamine receptor genes in the distal portion of ogy, 102(4), 350–356.
the long arm of chromosome 5 with systolic blood pressure variation. 72. Adlersberg, D., Parets, A. D., & Boas, E. P. (1949). Genetics of atheroscle-
7
7
Human Molecular Genetics, 7(9), 1379–1383. rosis: Studies of families with xanthoma and unselected patients with coro-
47. Risch, N. J. (2000). Searching for genetic determinants in the new mil- nary artery disease under the age of 50 years. JAMA, 141(4), 246–254.
lennium. Nature, 405(6788), 847–856. 73. Becker, D. M., Becker, L. C., Pearson, T. A., et al. (1988). Risk factors
48. Zhang, H., Liu, L., Wang, X., et al. (2007). Guideline for data analysis of in siblings of people with premature coronary heart disease. Journal of
genomewide association studies. Cancer Genomics Proteomics, 4(1), 27–34. the American College of Cardiology, 12(5), 1273–1280.
4
4